Category: Health

  • The Philadelphia scientists who studied garlic-flavored breast milk won a 2025 Ig Nobel Prize

    The Philadelphia scientists who studied garlic-flavored breast milk won a 2025 Ig Nobel Prize

    Philadelphia didn’t take home any Nobel Prizes this year, but work illuminating how babies respond to garlic-flavored breast milk at Monell Chemical Senses Center did get recognized by its satirical counterpart, the Ig Nobel Prize.

    Founded in 1991 by mathematician Marc Abrahams, the Ig Nobel Prize honors “achievements so surprising that they make people LAUGH, then THINK,” according to the Massachusetts-based organization’s website.

    Julie Mennella, a longtime scientist at the center in West Philadelphia, and Gary Beauchamp, Monell’s former director, won the prize earlier this fall for their 1991 study published in the academic journal Pediatrics that disproved popular folklore around breastfeeding.

    Their study examined whether eating garlic would flavor a mother’s breast milk and, if so, how a nursing baby would react to it.

    At the time, breastfeeding women were often told to eat bland foods, for fear their babies would reject strong flavors. However, the study’s results showed the opposite: Babies savored the garlic-flavored breast milk.

    “That simple, elegant study really showed how one of the first ways we learn about foods is through what our mothers eat,” Mennella said.

    These early life experiences shape food preferences and influence cultural food practices around the world, she emphasized. Babies whose mothers come from cultures in which garlic is a defining flavor would have experienced garlic long before their first meal.

    Mennella spoke with The Inquirer about the implications of her Ig Nobel Prize-winning work and her decades of research on flavor sciences and early nutritional programming.

    The following conversation has been lightly edited for length and clarity.

    What did you discover in your Ig Nobel Prize-winning study?

    We found in this study that not only did the milk get flavored with garlic, but contrary to a lot of the folklore, the babies actually liked it. They nursed longer when the milk was garlic-flavored than when it was bland and devoid of garlic.

    We went on to show that when women eat garlic, the flavor of amniotic fluid also gets altered.

    Through these first exposures, babies are learning about what mom is eating, what mom has access to, and what mom likes before their own first taste of solid food.

    What is the takeaway for breastfeeding mothers?

    Eat the healthy foods that you enjoy because your baby’s going to learn about the food. Food is much more than a source of calories. In many cases, it defines who we are as a people.

    What other flavors have you studied?

    A wide variety of flavors, from vanilla to even alcohol if a woman drinks it, get transmitted and flavors the milk. If women smoke, the tobacco flavor does, too. So it’s not only what you eat, but what you breathe.

    Why is it important for babies to learn about food this way?

    There’s a great story about the European rabbit (an animal that nurses), where they tagged the mother’s diet with juniper berry. What they were able to show is that in a group where the mothers ate juniper berry during either pregnancy or lactation, once those young rabbit pups left the nest, they were more likely to forage on juniper berry.

    So, she’s telling them, ‘These are the foods that are out there. I’m eating them. They’re safe.’ It’s really a very elegant, sustainable behavior, how moms transmit this information about the foods in the environment. She’s teaching her young and giving them an advantage early on.

    How long do these flavors last in the milk?

    Depending on the size of the chemical, some will get in fast. Garlic gets in a couple hours after the mom eats it, and then if she stops eating, it’s out of the milk like four or five hours later. The sensory experience of that baby is changing throughout the course of the day, day to day, depending on what she eats.

    What research have you been up to since?

    I’ve gone into so many different directions of looking at not only early flavor learning, but also nutritional programming. I also looked at the taste of medicine in children, looking at individual differences because taste is the primary reason for noncompliance. Children have a harder time because they can’t encapsulate the bad taste in a pill or tablet, so liquid medicines are particularly difficult.

    One study where we looked at variation in the taste of pediatric Motrin (among adult participants) was really interesting. Some people experience a tingle when they taste it. Others don’t. It makes you think that how one child tastes Motrin isn’t like how another does. If you don’t experience the tingle, or this burning sensation, all you taste is a sweet liquid, and those are the children that may be at risk of over-ingestion.

    What is your favorite project that you have worked on since the garlic study?

    I serendipitously found that another flavor that gets transmitted is alcohol, and that became a whole new area of research.

    We found that when women just have the equivalent of one or two glasses of wine or beer, not only did the alcohol get transmitted, but it flavored the milk. That became a lead article in the New England Journal of Medicine.

    At that time, there was talk about a folklore that women should drink when they’re breastfeeding, so they would make more milk. And contrary to that folklore, they actually made less milk.

    How did it feel to win an Ig Nobel?

    It was so nice to celebrate science. That’s really what that award does: It uses humor to teach about science.

  • Mark Hallett, world-renowned neuroscientist and groundbreaking researcher, has died at 82

    Mark Hallett, world-renowned neuroscientist and groundbreaking researcher, has died at 82

    Mark Hallett, 82, of Bethesda, Md., world-renowned scientist emeritus at the Maryland-based National Institute of Neurological Disorders and Stroke, former chief of the clinical neurophysiology laboratory at Brigham and Women’s Hospital in Boston, associate professor of neurology at Harvard Medical School, groundbreaking researcher, prolific author, mentor, and world traveler, died Sunday, Nov. 2, of glioblastoma at his home.

    Dr. Hallett was born in Philadelphia and reared in Lower Merion Township. He graduated from Harriton High School in 1961 and became a pioneering expert in movement, brain physiology, and human motor control.

    He spent 38 years, from 1984 to his retirement in 2022, at the National Institutes of Health in Bethesda and was clinical director and chief of the medical neurology branch of the National Institute of Neurological Disorders and Stroke. He and his colleagues examined the human nervous system and the brain, and their decades of research helped doctors and countless patients treat dystonia, Parkinson’s, and other neurodegenerative diseases.

    “When I met him, I was in bad shape,” a former patient said on Instagram. “I’d also been told … that no one would ever figure out the source of my illness. … He and his team diagnosed me, and thereby, I’m pretty sure, saved my life”

    Dr. Hallett told the Associated Press in 1992: “The more that we know about the way these cells function, the better off we are.”

    He founded the NINDS’ human motor control section in 1984, cofounded the Functional Neurological Disorder Society in 2018, and served as the society’s first president. He cultivated thousands of colleagues around the world, and they called him a “giant in the field” and a “global expert” in online tributes.

    Barbara Dworetzky, current president of the FNDS, said Dr. Hallett was a “brilliant scientist, visionary leader, and compassionate physician whose legacy will endure.” Former NIH colleagues called his contributions “astounding” and said: “The scope and impact of Dr. Hallett’s work transcend traditional productivity metrics.”

    He chaired scientific committees and conferences, and supervised workshops for many organizations. He earned honorary degrees and clinical teaching awards, and mentored more than 150 fellows at NIH. “Our lab’s demonstration of trans-modal plasticity in humans was another milestone,” he told the NIH Record in 2023. “And, of course, I am particularly proud of the fellows that I have trained and their accomplishments.”

    In a tribute, his family said those he mentored “valued his intellect, his encouragement, his kindness, and his humor.”

    Dr. Hallett and his wife, Judy, married in 1966.

    Dr. Hallett had planned to study astronomy at Harvard University after high school. Instead, he earned a bachelor’s degree in biology in 1965 and a medical degree at Harvard Medical School in 1969. He completed an internship at the old Peter Bent Brigham Hospital, now part of Brigham and Women’s, and joined a research program at the NIH in 1970 to fulfill his military obligation during the Vietnam War.

    A fellowship in neurophysiology and biophysics at the National Institute of Mental Health sparked his interest in motor control, and he served a neurology residency at Massachusetts General Hospital in 1972 and a fellowship at the Institute of Psychiatry in London in 1974.

    He returned to Brigham and Women’s in 1976 to supervise the clinical neurophysiology laboratory and rose to associate professor of neurology at Harvard. In 2019, he earned the Medal for Contribution to Neuroscience from the World Federation of Neurology, and former colleagues there recently said his work “had a lasting global impact and shaped modern clinical and research practice.”

    He also studied the scientific nature of voluntary movement and free will. He wrote or cowrote more than 1,200 scientific papers on all kinds of topics, edited dozens of publications and books, and served on editorial boards.

    He was past president of the International Federation of Clinical Neurophysiology and the International Parkinson and Movement Disorder Society, and vice president of the American Academy of Neurology.

    At Harriton, he was senior class president, a star tennis player, and a leading man in several theatrical shows. “The only time he disobeyed his parents,” his family said, “was when he decided to leave Philadelphia to attend Harvard College.”

    Mark Hallett was born Oct. 22, 1943. The oldest of three children, he was a natural nurturer, a longtime summer camp counselor, and the winner of an Alfred P. Sloan Foundation national scholarship award in high school.

    He grew up in Merion and met Judith Peller at a party in 1963. They married in 1966 and had a son, Nicholas, and a daughter, Victoria.

    Dr. Hallett (center) was a star on the Harriton High School tennis team.

    Dr. Hallett was an avid photographer and a master of the family group shot. He championed a healthy work-life balance, and his family said: “He eagerly built sand castles, skipped stones, and started pillow fights. His easy laugh was contagious.”

    He enjoyed hiking, biking, jazz bands, and organizing family vacations. “He was a natural leader,” his son said, “self-assured and patient of others, with a deep sincerity and a desire to help people.”

    His daughter said: “People were constantly turning to him for medical advice, and he was always willing and eager to help.”

    His wife said: “He was very high energy. He brought out the best and the most in young people. He made them feel good about themselves.”

    Dr. Hallett traveled the world on business and family vacations.

    In addition to his wife and children, Dr. Hallett is survived by two granddaughters, a sister, a brother, and other relatives.

    A memorial service is to be held later.

    Donations in his name may be made to the Functional Neurological Disorder Society, 555 E. Wells St., Suite 1100, Milwaukee, Wis. 53202; and the International Parkinson and Movement Disorder Society, 555 E. Wells St., Suite 1100, Milwaukee, Wis. 53202.

  • One year of inspections at Children’s Hospital of Philadelphia: October 2024 – September 2025

    One year of inspections at Children’s Hospital of Philadelphia: October 2024 – September 2025

    Pennsylvania’s Department of Health investigated several complaints at the Children’s Hospital of Philadelphia between October 2024 and September of this year but did not cite the hospital for any safety violations.

    Here’s a look at the publicly available details:

    • Oct. 30, 2024: Inspectors came to investigate a complaint but found the hospital was in compliance. Complaint details are not made public when inspectors determine it was unfounded.
    • Jan. 27, 2025: Inspectors came to investigate a complaint but found the hospital was in compliance.
    • Feb. 18: Inspectors came to investigate a complaint but found the hospital was in compliance.
    • March 11: Inspectors came to investigate a complaint but found the hospital was in compliance.
    • May 15: Inspectors came to investigate a complaint but found the hospital was in compliance.
  • Temple Health reported a $15 million operating loss in the first quarter of fiscal 2026

    Temple Health reported a $15 million operating loss in the first quarter of fiscal 2026

    Temple University Health System reported a $15 million operating loss in the three months that ended Sept. 30.

    The result for the first quarter of fiscal 2026 was an improvement from the North Philadelphia nonprofit’s $17 million loss last year.

    “We’re pretty happy where we are,” CEO Mike Young said Wednesday. Revenue was above budget and labor costs were on budget in the first quarter for the first time in several years.

    Here are some details:

    Revenue: Total revenue was $800 million, up 13% from $712.5 million a year ago. Outpatient revenue increased by nearly $62 million, much of it from the health system’s specialty and retail pharmacy business.

    Temple participates in a federal program for safety-net hospitals that allows it to buy certain drugs at a discount and then get full reimbursement from insurance companies.

    Expenses: Temple noted in its report to municipal bond investors Tuesday that salaries, including higher pay rates for nurses, and higher drug spending for outpatient infusions and other pharmacy business were the biggest expense increases.

    Notable: On the labor front, several job categories remain hard to fill, Young said. Those are CT techs, nurse anesthetists, and lab techs. “Other than those three [specialties], it’s not where it was three years ago, where you couldn’t find anybody,” he said.

  • Inside a Kensington wound care clinic

    Inside a Kensington wound care clinic

    In a small clinic room at Mother of Mercy House on Allegheny Avenue in Kensington, Emma Anderson unwrapped a bandage from a man’s swollen hand.

    “It hurts really bad in the cold,” the man said, wincing at the inflamed wound that covered most of a right-hand finger.

    Cleaning it with saline solution proved so painful that Anderson, an EMT and St. Joseph’s University student, let the patient take the lead, wiping carefully at the yellowish-white tissue at the center of the wound.

    It was his second time attending the wound care clinic at Mother of Mercy, the Catholic nonprofit that twice a week opens its doors to people with addiction dealing with the serious skin lesions, caused by the animal tranquilizer xylazine, that can develop into wounds so severe the only treatment is amputation.

    Called “tranq” on the streets, xylazine was never approved for human use and has wreaked havoc across the city since dealers began adding it to fentanyl to extend the opioid’s short-lived high.

    In the five years since it emerged as a threat, amputations among opioid users have more than doubled. The Philadelphia drug supply is now changing again, and though emergency rooms in the last year have treated fewer xylazine wounds, the crisis is far from over.

    The man who visited Mother of Mercy’s clinic on a recent Tuesday, who gave only his first name, Steven, because of the stigma surrounding drug use, noticed the alarming wound on his hand a few weeks ago.

    Steven had seen people sleeping on the streets with flies hovering around their gaping wounds. He had hoped that he could avoid a wound himself: He smokes fentanyl, instead of injecting it, and knows that injection drug users are generally at a higher risk for skin infections. But, like many people who smoke their drugs, he had developed a wound anyway.

    “Believe it or not,” Steven said, between deep breaths during the painful cleaning, “I actually was an EMT myself at one point.”

    ‘How did we let it get this bad?’

    Mother of Mercy, founded in 2015 in Kensington, partners with St. Joseph’s Institute of Clinical Bioethics to host the clinics. The institute, headed by Father Peter Clark, a Jesuit priest and a bioethicist at several area hospitals, has long held a monthly health clinic at the nonprofit’s Kensington headquarters.

    In the last year, they expanded the program to offer more wound care opportunities to a community increasingly in need of them.

    Father Peter Clark, the director of the Institute of Clinical Bioethics at St. Joseph’s University, and Ean Hudak, a St. Joseph’s student and staffer at the Mother of Mercy House wound care clinic, assist a person who had fallen unconscious on Allegheny Avenue in Kensington.

    “To be physically down here in the heart of it, and seeing it on a weekly, monthly basis, it opens your eyes. How did we let it get this bad?” said Steven Silver, the assistant director of research and development at St. Joseph’s, who was welcoming clients at the door on a recent clinic day.

    The program is staffed by medical students and undergraduates, all trained in wound care. Many say the work they do at the clinic is unlike any medical training they’ve been offered at school.

    Undergraduates like Anderson and Ean Hudak, who takes shifts at the clinic in between applying to nursing schools, say they’re hoping to use their experience as they pursue careers in the medical field.

    On Tuesdays and Thursdays, organizers serve hot meals and wait in the small clinic room for patients to trickle in, usually about 20 a week.

    Once a month, the team takes to the streets with wound care supplies, such as bandages, saline sprays, and antiseptic cleansers. They look for people on the streets who may not be able to reach the clinic.

    Clark said the clinic stepped up its hours in an effort to help patients keep their wounds clean more consistently — and hopefully prevent more amputations. “It’s increasing [patients’] ability to know what to do and how to keep the wounds clean — hopefully to help them out,” he said.

    The trust factor

    This year, medetomidine, another animal tranquilizer that causes severe withdrawal, has supplanted xylazine’s dominance in the Philadelphia area drug supply. Fewer patients addicted to opioids are visiting emergency rooms with soft-tissue damage, according to city data.

    But it’s unknown how medetomidine affects those wounds, and there are still enough people suffering from them in Kensington, the epicenter of the city’s opioid crisis, that the clinic felt it necessary to increase its hours.

    Hosting more frequent clinics also deepens relationships with patients. “People are coming back, which is good,” Clark said. “The trust factor is a huge issue.”

    Many of the clinic’s patients avoid hospitals, fearing long waits for care: “At the ERs, they wait eight hours and they sign themselves out, or they’re coming down from a high, and nobody’s taking care of the withdrawal,” Clark said. “It’s a big mess.”

    At the clinic, staff are regularly on the phone with wound care physicians at Temple University Hospital, who can flag patients with xylazine wounds and get them prompt care before they enter withdrawal, he said.

    They also connect patients with housing, inpatient rehabs, and hospital care, for those with wounds too serious for the clinic to handle.

    Several weeks ago, they called an ambulance to get a man with a wound that exposed his bone to the hospital.

    Staff collect data to share with area hospitals so physicians can get a better understanding of the situation on the street — measuring patients’ wounds, collecting demographic data, and asking patients about which drugs they use.

    Each leaves the clinic with a hospital bracelet documenting the care they’ve received so staff can keep track of their care from week to week.

    ‘It’s always an uphill battle’

    Not all patients at the clinic are suffering from xylazine wounds. On a recent weekday, one man asked for help bandaging scrapes on his knuckles. He’d tried to fight someone who was stealing his belongings.

    Another man said he’d been robbed and pepper-sprayed and asked staff to help wash the last traces of Mace out of his eyes.

    As staffers looked for eyedrops among their medical supplies, Clark poked his head into the room. “We need someone with Narcan,” he said, referring to the opioid overdose-reversing spray.

    Across the street, a man was slumped on a stoop, unresponsive.

    Clark and Hudak dodged cars on Allegheny Avenue, knelt down by the man, and managed to gently shake him awake.

    Slowly, he revived enough to speak a bit and showed them a wound on his leg, which they cleaned and wrapped in gauze. “You have some cracked skin — do you want us to put some moisturizer on your hands?” Hudak asked.

    With temperatures dropping, the team is worried that patients’ skin will dry out, making their wounds more painful. (The summer months present a different challenge, with wounds leaking fluids.) And many patients may be too cold to travel to the clinic, making the monthly street rounds even more crucial.

    “It’s always an uphill battle,” Hudak said.

  • Jefferson Health hit with federal WARN Act lawsuit

    Jefferson Health hit with federal WARN Act lawsuit

    A lawsuit filed Tuesday in Philadelphia accused Jefferson Health of violating federal labor rules when it laid off 1% of its 65,000 employees in October and this month without providing a 60-day notice.

    The purported class-action lawsuit says the proposed lead plaintiff, Ciara Brice, lost her job as a medical assistant on Nov. 12 with no notice and has not received the severance pay she was promised.

    Brice was not available for comment, said her lawyer, Jeremy E. Abay, with Philadelphia law firm Pond Lehocky Giordano Inc.

    The Worker Adjustment and Retraining Notification Act has a complicated rubric for determining when a mass layoff requires advance notification, which is filed with state labor departments. One of the triggers is an employer cutting at least 500 jobs, according to Abay.

    Even though the layoffs happened throughout Jefferson’s entire footprint from South Jersey to near Scranton, Abay said notice is required because Jefferson operates as a single entity.

    “We believe the facts will show that there was no violation of the federal WARN Act,” Jefferson said in a statement.

    The nonprofit filed a notice of 108 layoffs at Jefferson Cherry Hill Hospital, Jefferson Stratford Hospital, and Jefferson Washington Township Hospital because New Jersey has its own rules, Abay said.

    In August, Jefferson reported a $195 million operating loss on $15.8 billion in revenue for the year that ended June 30.

    The nonprofit, which grew through acquisitions from three hospitals in Philadelphia in 2015 to more than 30 now, provided no details when it announced the layoffs in mid-October.

    That layoff was part of a series of large job cuts starting in the summer of 2023, but may have been the first time patient-facing workers like Brice were hit.

    The lawsuit seeks back pay, benefits, and damages for each laid-off employee who did not receive a 60-day notice.

    Editor’s note: The headline on this article has been updated to clarify that a lawsuit claims violations.

  • A 3-year-old was starved and beaten to death. Lawsuit accuses Philadelphia FIGHT of failing to report ongoing abuse.

    A 3-year-old was starved and beaten to death. Lawsuit accuses Philadelphia FIGHT of failing to report ongoing abuse.

    Three-year-old Hope Jones weighed 24.5 pounds, less than 99% of children her height and age, just a month before she died in July 2022.

    The child was starved and beaten up by her foster parent, a distant relative from Southwest Philadelphia who pleaded no contest to third-degree murder over Hope’s death.

    A child welfare agency, Northeast Treatment Centers, paid $6.5 million to settle a lawsuit accusing it of failing to supervise Hope’s care. And in a rare move, one of their social workers was charged criminally but later cleared of wrongdoing in trial.

    A new federal lawsuit is pointing a finger in another direction. It accuses medical providers from Philadelphia FIGHT, a community health nonprofit based in Center City, of failing to investigate or report abuse despite a series of red flags from Hope’s wellness checks.

    The lawsuit, filed Friday in the Eastern District of Pennsylvania, is against the United States because FIGHT is a federally qualified health center and thus receives funding and operates with requirements from the government.

    Philadelphia’s U.S. Attorney’s Office declined to comment. FIGHT did not respond to a request for comment.

    The lawsuit is not only the latest legal fallout from Hope’s death, but the latest in litigation brought after children who were part of the city’s child welfare system have been harmed.

    This fall, child welfare agencies were sued over the death of 20-month-old Syvir Hill, who was allegedly drowned by another child in a bath unsupervised, and that of 11-year-old Nayshaun Williams, who died of an asthma attack after a school nurse repeatedly raised concerns that he was not receiving adequate medical treatment.

    The city and its affiliated agencies were sued nearly 70 times between 2012 and 2024 after kids in their care were killed, sexually abused, or injured, an Inquirer/Resolve Philly investigation found. And at least 50 of these lawsuits led to settlements or verdicts of $1 million or more.

    Two agencies declined to extend their contract with the city last year, citing litigation insurance costs.

    The new lawsuit on behalf of Hope’s biological family extends the circle of litigants to include medical providers.

    “It’s another group of professionals that failed Hope,” said Sherrell Dandy, one of the Kline & Specter attorneys representing the family.

    Child welfare services were involved in Hope’s life from her first days on Earth, according to the complaint. Her mother and the infant tested positive for marijuana after the delivery, and the Philadelphia Department of Human Services placed the infant under its care.

    Hope became a FIGHT patient, and her first few visits as a baby went well, the lawsuit says. She was “well-developed and well-nourished,” the complaint says, and had a “good appetite.”

    Hope’s weight reached the 98th percentile at her 15-month wellness visit, in the summer of 2020, but she fell off the growth chart steadily after the following November when she was placed in foster care with a distant relative, the complaint says. Hope failed to meet developmental milestones and lost teeth, a couple times without explanation and another time following an alleged fall.

    The child’s medical records note that she developed an abnormal gait, ate her own feces, and was eating extremely fast followed by periodically vomiting, the suit says.

    The FIGHT physicians did refer Hope to an orthopedic specialist because of her gait, but the lawsuit says that they failed to recognize it as “clinical indicators of severe weight loss and underlying caloric deprivation, starvation, and neglect.”

    Hope’s weight fell to the single digits as summer 2022 approach. She was rushed to the hospital that July and was pronounced dead. The Philadelphia Medical Examiner’s Office determined that her cause of death was multiple blunt impact injuries, and the manner of death was homicide.

    “The hallmark for health is growth,” said Nadeem Bezar, another Kline & Specter attorney. “During those visits there were alarming things that were never followed up on.”

    A previous version of the lawsuit was filed against FIGHT in federal court in February. A judge dismissed that case in March because Hope’s estate had other administrative remedies to pursue before filing a lawsuit, and said that the appropriate defendant would be the United States. The new lawsuit says that all administrative remedies were exhausted and the government is the only defendant.

  • A Philadelphia jury reached $35 million verdict against Main Line Health and Penn Medicine for cancer misdiagnosis

    A Philadelphia jury reached $35 million verdict against Main Line Health and Penn Medicine for cancer misdiagnosis

    A Philadelphia jury reached $35 million verdict last week against Main Line Health and the University of Pennsylvania Health System for a cancer misdiagnosis that led a then-45-year old Philadelphia resident to undergo a total hysterectomy in 2021.

    Main Line discovered later that the biopsy slides used to make the diagnosis in February 2021 were contaminated. The cancer diagnosis was due an error that involved a second person’s DNA, not that of the plaintiff, Iris Spencer, who did not have cancer.

    Main Line settled with Spencer in 2022 for an undisclosed amount, so it won’t have to pay its share of the verdict.

    The jury found Penn and its physician, Janos Tanyi, a gynecological oncologist, liable for $12.25 million, or 35%, of the total awarded in damages for her unnecessary hysterectomy. The lawsuit said Spencer suffers from “surgically-induced menopause.”

    The lawsuit against Penn and Tanyi said the physician did not do enough to resolve a conflict between biopsy results at Main Line and those at Penn, where Spencer sought a second opinion.

    A Penn biopsy did not find cancer. Other tests were also negative, but Spencer did not know about those results.

    “The verdict affirms the central importance of the patient and the doctor’s obligation to inform the patient of all of the test results, of all of her options, and that she shouldn’t be dismissed because she’s a patient and not a doctor,” Spencer’s lawyer, Glenn A. Ellis, said Monday.

    The $35 million verdict is Philadelphia’s largest this year for medical malpractice, according to data from the Philadelphia Court of Common Pleas.

    Medical malpractice costs have been rising throughout healthcare. A factor in Pennsylvania is a 2023 rule change that allowed more flexibility in where cases can be filed.

    In 2023, a Philadelphia jury issued a state record $183 million verdict against the Hospital of the University of Pennsylvania in a birth injury case.

    A laboratory mistake

    Spencer’s troubles started in February 2021 at Main Line’s Lankenau Medical Center where her biopsy found that she had cancer in the lining of her uterus despite the lack of symptoms.

    For a second opinion, Spencer saw Tanyi at Penn a few days later. A repeat biopsy came back negative, according to Spencer’s complaint that was filed in early 2023. Tanyi also performed other tests, all of which came back negative, but he did not share that information with Spencer, the complaint says.

    After Tanyi performed the complete hysterectomy on March 8, 2021, Penn’s pathology laboratory found no cancer in the tissues that had been removed from Spencer’s body.

    That’s when Spencer, who has since moved to Georgia, went back to Lankenau seeking an explanation. Seven months later, Main Line informed her that she never had cancer.

    Main Line and Spencer subsequently “reached an amicable full and final settlement to resolve and discharge all potential claims for care involving the health system,” Main Line said in a statement. Main Line did not participate in the trial.

    Penn said in a statement: “We are disappointed by the jury’s verdict in this case that was unmoored to the evidence presented at trial on negligence and damages. Our physician reasonably relied on the pathology performed at a hospital outside our system that revealed a very aggressive cancer.”

    Penn said it plans to appeal the verdict, which could increase by more than $2 million if the court approves a motion for delay damages that Ellis filed Saturday.

  • Director of Penn State Cancer Institute resigns after Spotlight PA investigation about chemo errors, ‘toxic’ leadership

    Director of Penn State Cancer Institute resigns after Spotlight PA investigation about chemo errors, ‘toxic’ leadership

    This story was produced by the State College regional bureau of Spotlight PA, an independent, nonpartisan newsroom dedicated to investigative and public-service journalism for Pennsylvania. Sign up for Talk of the Town, a daily newsletter of local stories that dig deep, events, and more from north-central PA, at spotlightpa.org/newsletters/talkofthetown.

    Raymond Hohl, the director of the Penn State Cancer Institute, resigned Friday following a Spotlight PA investigation into his care of patients and leadership of the center.

    Hohl made the decision “thoughtfully and with the best interests of the Institute in mind,” according to an internal email, which was signed by Karen Kim, dean of the Penn State College of Medicine, and Michael Kupferman, CEO of Penn State Health. The email says he will remain a faculty member of the university’s medical college.

    Hohl started as director in 2014 with the goal of achieving National Cancer Institute designation, a prestigious federal recognition, for the center based in the Milton S. Hershey Medical Center. The university invested hundreds of millions of dollars in the cancer center in pursuit of designation, records show.

    A Spotlight PA investigation published Nov. 20 found that Hohl was the subject of a series of damning internal reviews between early 2022 and mid-2023. The reviews found a series of problems with Hohl’s care of at least 10 patients. His sloppy recordkeeping caused multiple errors. Several of Hohl’s patients received extra doses of chemotherapy by accident. Others faced unexplained delays in changing their treatment, or having scans done to check whether their cancer had progressed, according to documents obtained by the newsroom.

    Penn State’s reviews also concluded that Hohl perpetuated a toxic culture of fear and mistrust that chewed up doctors and researchers, who left the organization in droves during this time period. Getting federal designation was Hohl’s top priority, but after nearly a decade under his leadership and some $410 million invested, the cancer institute was “significantly behind where it needs to be,” a December 2022 review found. Records show that Hohl disputed the findings and offered a rosier assessment at the time.

    Penn State Health’s former chief executive officer and former chief operating officer, as well as the hospital’s then-chief medical officer and two medical school deans, including Kim, had extensive knowledge of these problems, records show.

    In 2023, leaders privately considered removing Hohl as director of the cancer institute, internal records show. The doctor kept his position and was placed on a two-month performance improvement plan, under which he was asked to adhere to national guidelines for cancer treatment, demonstrate active listening skills, and show that he was a team player, among other goals.

    In May 2024, Penn State quietly removed Hohl’s oversight of clinical care, a move the Penn State Health spokesperson declined to explain in September 2025. Hohl was still seeing patients as of early 2025.

    Following publication of Spotlight PA’s investigation, Penn State Health said in a statement: “We believe the reporting by this outlet is based almost entirely on materials more than two years old and it does not provide an accurate representation of Penn State Cancer Institute (PSCI) as it exists today. During the last two years — we have made significant changes to PSCI’s leadership, staffing, operations, clinical capabilities and research processes.”

    According to the internal announcement, institute deputy director Jeff Peters will be the interim director of the cancer center.

    SUPPORT THIS JOURNALISM and help us reinvigorate local news in north-central Pennsylvania at spotlightpa.org/donate. Spotlight PA is funded by foundations and readers like you who are committed to accountability and public-service journalism that gets results.

  • Temple Health says its new medical malpractice strategy is working

    Temple Health says its new medical malpractice strategy is working

    Temple University Health System‘s medical malpractice expenses have surged in the two years that ended June 30 as part of a campaign to reduce financial risk by settling old cases.

    The hope is that “aggressively” settling cases will pay off over the next few years by reducing medical malpractice expenses, Michael DiFranco, the health system’s chief accounting officer, told investors during a conference call last week on the health system’s fiscal 2025 financial results.

    Temple Health has 12,000 faculty members and employees who work mainly on five hospital campuses. Its fiscal 2025 revenue was $3.3 billion.

    Temple’s annual medical malpractice expenses increased nearly fourfold, to $117.8 million in fiscal 2025 from $31.6 million two years ago. Over the same period, it cut its reserves for future expenses by $88 million, or 22%. Temple’s reserves peaked at $402.9 million in 2023.

    Rising medical malpractice costs are reverberating throughout healthcare. Tower Health recently boosted its reserves after its auditor decided they should be higher to deal with anticipated claims. Lifecycle Wellness, a birth center in Bryn Mawr, blamed its decision to stop delivering babies in February in part on rising medical malpractice costs.

    The average number of medical malpractice lawsuits filed in Philadelphia every month has risen from 34 and 35 in the two years before the pandemic to 51 last year and 52 so far this year, according to the Philadelphia Court of Common Pleas. In additional to lawsuits against hospitals, the tally includes litigation against physicians, nursing homes, and other healthcare providers.

    Contributing to the increase was a rule change at the beginning of 2023 that allowed more cases to be filed in Philadelphia rather than the county where an injury occurred. Malpractice lawyers say they like to file in Philadelphia because the system for trying cases is efficient. Health systems often note that Philadelphia juries sometimes award large verdicts.

    A ‘wake-up call’ at Temple

    Temple Health started rethinking its medical malpractice strategy after John Ryan started as general counsel in January 2022. A month before he started, The Inquirer published an article about three suicides at Temple Episcopal Hospital in 2020. At least two of the families sued Temple.

    “That was a wake-up call,” Ryan said in a recent interview on his approach to handling malpractice cases.

    Then in May 2023, a Philadelphia jury hit Temple with a $25.9 million verdict in a case involving a delayed diagnosis of a leg injury leading to an amputation.

    After that loss, Temple changed the kinds of outside lawyers it hires to defend it in malpractice cases, Ryan said, swapping medical malpractice specialists for commercial litigators from firms like Blank Rome, Cozen O’Connor, and Duane Morris. Such lawyers cost more, but it’s paying off, he said.

    “The settlements we’re getting from the plaintiff lawyers, because they can see that we’re serious, are much better,” Ryan said. The two Episcopal cases were settled this year for undisclosed amounts, according to court records. A birth-injury lawsuit against Temple University Hospital in federal court settled for $8 million this month.

    In 2024, a jury awarded $45 million to a teen who was shot in the neck and suffered brain damage from aspirating food soon after his release from Temple. Temple appealed and the judge who oversaw the original trial ordered a new one. That case then settled at the end of October for an undisclosed amount.

    The new approach has helped Temple reduce the number of outstanding cases at any one time to 65 or so now compared to 110 three years ago, according to Ryan.

    Temple is using the money it is saving on malpractice costs to invest in better and safer care, Ryan said. “That’s not a byproduct of all we’re trying to do as the lawyers. It’s the goal,” he said.

    Inquirer staff reporter Abraham Gutman contributed to this article.